Monday, October 26, 2026 · Daily editionET --:--:--

Under way, not recruiting

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging

NCT06654271 · Vanderbilt University Medical Center · Updated 20 Oct 2025

What is being tested
Robotic assisted bronchoscopy (RAB); Electromagnetic navigation bronchoscopy (ENB)
For
Peripheral Pulmonary Lesion; Lung Nodule, Solitary
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 440 people. The full rules are on the registry page.
Where
United States (4 sites)
When
Starts or started 11 Nov 2024, ends 14 Oct 2026. Registered 23 Oct 2024.
Results
None posted yet.

In the researchers' words

RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoing bronchoscopy to biopsy a pulmonary lesion.
ClinicalTrials.gov, NCT06654271

Sites

  • Rush University Medical CenterChicago, Illinois, United States
  • Johns Hopkins UniversityBaltimore, Maryland, United States
  • Vanderbilt University Medical CenterNashville, Tennessee, United States
  • Vanderbilt University Medical CenterNashville, Tennessee, United States